| Title |
Integrated cancer cell-specific single-cell RNA-seq datasets of immune checkpoint blockade-treated patients
|
|---|---|
| Published in |
bioRxiv, January 2024
|
| DOI | 10.1101/2024.01.17.576110 |
| Pubmed ID | |
| Authors |
Mahnoor N. Gondal, Marcin Cieslik, Arul M. Chinnaiyan |
X Demographics
The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 23% |
| Russia | 1 | 8% |
| Saudi Arabia | 1 | 8% |
| Spain | 1 | 8% |
| Unknown | 7 | 54% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 77% |
| Scientists | 3 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 April 2024.
All research outputs
#5,258,260
of 25,637,545 outputs
Outputs from bioRxiv
#2,490
of 4,046 outputs
Outputs of similar age
#75,642
of 343,066 outputs
Outputs of similar age from bioRxiv
#123
of 229 outputs
Altmetric has tracked 25,637,545 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,046 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.9. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,066 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 229 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.